These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21471427)

  • 21. Rising HIV infection rates in Ho Chi Minh City herald emerging AIDS epidemic in Vietnam.
    Lindan CP; Lieu TX; Giang LT; Lap VD; Thuc NV; Thinh T; Lurie P; Mandel JS
    AIDS; 1997 Sep; 11 Suppl 1():S5-13. PubMed ID: 9376101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: a cross-sectional study.
    Camoni L; Regine V; Salfa MC; Nicoletti G; Canuzzi P; Magliocchetti N; Rezza G; Suligoi B;
    Scand J Infect Dis; 2009; 41(6-7):520-3. PubMed ID: 19415569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'They can't solve the problem without us': a qualitative study of stakeholder perspectives on user involvement in drug treatment services in England.
    Patterson S; Weaver T; Agath K; Albert E; Rhodes T; Rutter D; Crawford M
    Health Soc Care Community; 2009 Feb; 17(1):54-62. PubMed ID: 18564192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.
    Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
    J Subst Abuse Treat; 2007 Jun; 32(4):423-9. PubMed ID: 17481466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Eyes Wide Shut": narratives of women living with hepatitis C in Australia.
    Crockett B; Gifford SM
    Women Health; 2004; 39(4):117-37. PubMed ID: 15691088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risky injecting practices associated with snowballing: a qualitative study.
    Wilkins L; Bissell P; Meier PS
    Drug Alcohol Rev; 2010 May; 29(3):256-62. PubMed ID: 20565517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users.
    Kretzschmar M; Wiessing L
    AIDS; 2008 Aug; 22(13):1527-37. PubMed ID: 18670211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multilayered Stigma and Vulnerabilities for HIV Infection and Transmission: A Qualitative Study on Male Sex Workers in Zimbabwe.
    Tsang EY; Qiao S; Wilkinson JS; Fung AL; Lipeleke F; Li X
    Am J Mens Health; 2019; 13(1):1557988318823883. PubMed ID: 30819062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
    Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
    AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The depiction of stigmatization in research about hepatitis C.
    Paterson BL; Backmund M; Hirsch G; Yim C
    Int J Drug Policy; 2007 Oct; 18(5):364-73. PubMed ID: 17854724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: recent French data--the ANRS-Coquelicot Study.
    Jauffret-Roustide M; Emmanuelli J; Quaglia M; Barin F; Arduin P; Laporte A; Desenclos JC
    Subst Use Misuse; 2006; 41(10-12):1603-21. PubMed ID: 17002994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    Treloar C; Newland J; Rance J; Hopwood M
    J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
    Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS
    PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users].
    Wang YC; Xu SH; Li XH; Song AJ; Jia XR; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):777-9. PubMed ID: 17299963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
    Imani R; Karimi A; Rouzbahani R; Rouzbahani A
    East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.